ConductScience.org, home

Library / Trial comparisons

Ketamine vs Propofol: Number of Patients Who Develop Postoperative Delirium

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

Measures 6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNoteSource
Risk in group 100.00000000000000001390.133wilsonClinicalTrials.gov
Risk in group 20.04170.007390.202wilsonClinicalTrials.gov
Risk difference, group 1 minus group 2-0.0417-0.2020.0959newcombe hybrid scoreClinicalTrials.gov
Risk ratio, group 1 over group 2loga group has no participants with the outcomeClinicalTrials.gov
Odds ratio, group 1 over group 2loga cell of the two-by-two table is zeroClinicalTrials.gov
Number needed to treat, for one fewer participant with the outcome on Ketamine than on Propofol24from the risk difference intervalthe interval includes no differenceClinicalTrials.gov

Groups 2

Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov codeSource
Group 1KetamineKetamine induction~Ketamine: Ketamine used for induction025OG000ClinicalTrials.gov
Group 2PropofolPropofol induction~Propofol: Propofol used for induction124OG001ClinicalTrials.gov

Outcome 5

FieldValueSource
TypeSECONDARYClinicalTrials.gov
TitleNumber of Patients Who Develop Postoperative DeliriumClinicalTrials.gov
Description
Delirium was defined as a positive CAM (Confusion assessment method) score. CAM score was recorded every 12 hours postoperatively as per routine. The CAM consists of 4 features: 1-Onset, 2-Inattention, 3-Disorganized thinking, and 4-altered level of consciousness. The diagnosis of delirium by CAM is based on the presence of features 1 and 2, and either 3 or 4. The score is either positive or negative. Positive means the patient has delirium and negative indicates the patient is not delirious.
ClinicalTrials.gov
Time frameBaseline (preoperative cognitive tests) to hospital discharge or 10 days postoperatively whichever came first.ClinicalTrials.gov
PopulationClinicalTrials.gov

Trial 8

FieldValueSource
TitleThe Impact of Ketamine on Postoperative Cognitive Dysfunction, Delirium, and Renal DysfunctionClinicalTrials.gov
NCT numberNCT02554253ClinicalTrials.gov
PhasesPHASE2ClinicalTrials.gov
ConditionsCognitive Disorders, Delirium, Acute Kidney InjuryClinicalTrials.gov
InterventionsKetamine, PropofolClinicalTrials.gov
Lead sponsorMayo ClinicClinicalTrials.gov
Results first posted2022-02-15ClinicalTrials.gov
Results on ClinicalTrials.govhttps://clinicaltrials.gov/study/NCT02554253?tab=resultsClinicalTrials.gov

Source 4

FieldValueSource
Releasetrial-comparisons-2026-03-23-0.1.0ClinicalTrials.gov
Release manifest SHA-256f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57ClinicalTrials.gov
AACT copy2026-03-23ClinicalTrials.gov
Tables readoutcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquetClinicalTrials.gov

The same record as JSON

Release trial-comparisons-2026-03-23-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.